Autologous CARTmeso/19 Against Pancreatic Cancer
NCT03497819
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL:
CARTmeso CART19
Sponsor
First Affiliated Hospital of Wenzhou Medical University